Invetech Joins ATMI Roundtable Session at ISCT 2012

4 June 2012

In addition to presenting at the 18th Annual ISCT meeting (view details here), Invetech's Director of Life Science and Pharmaceutical, David James, will be joining the roundtable discussion:

Cell Therapy industrialization challenges: From R&D to commercialization
June 7, ISCT 2012 Annual Conference Grand Ballroom A.

Join the experts for an exciting exchange of ideas about:

  • Process Development & Product Integrity
  • Large Scale Manufacturing & GMP Standards
  • Commercialization Strategy & Economics

12:30 pm to 12:45 pm
From Academics to industrialization: Process Development Challenges
Sarah Snykers , R&D Manager, Promethera Biosciences

12:45 pm to 1:00 pm
From bench to commercial-scale stem cell bioprocessing systems
Joe Castillo, Cell Culture Director, ATMI Life Sciences

1:00 pm to 1:15 pm
From manual to automated process
David James, Director Life Science and Pharmaceutical, Invetech

1:15 pm to 1:30pm Roundtable Discussion
1:30 pm to 1:45pm Luncheon

18th Annual ISCT Meeting
June 5-8, 2012
Sheraton Seattle, Seattle, WA, USA

Challenges for Cell Therapies Manufacturing

Further Press Information

Alan Morris, Phone: +613 9211 7815, Fax: +613 9211 7703. Media Inquiries.